Comparison of Immunohistochemistry and Direct Sanger Sequencing for Detection of the BRAFV600E Mutation in Thyroid Neoplasm
Hye-Seon Oh (Oh HS), Hyemi Kwon (Kwon H), Suyeon Park (Park S), Mijin Kim (Kim M), Min Ji Jeon (Jeon MJ), Tae Yong Kim (Kim TY), Young Kee Shong (Shong YK), Won Bae Kim (Kim WB), Jene Choi (Choi J), Won Gu Kim (Kim WG), Dong Eun Song (Song DE)
Endocrinol Metab. 2018;33(1):62-69.   Published online 2018 Jan 30     DOI:
Citations to this article as recorded by Crossref logo
An effective approach for BRAF V600E mutation analysis of routine thyroid fine needle aspirates
Tanupriya Agrawal, Liqiang Xi, Winnifred Navarro, Mark Raffeld, Snehal B. Patel, Mark J. Roth, Joanna Klubo‐Gwiezdzinska, Armando C. Filie
Cytopathology.2022; 33(3): 344.     CrossRef
A dual identification strategy based on padlock ligation and CRISPR/Cas14a for highly specific detection of BRAF V600E mutation in clinical samples
Weicheng Shi, Yao Gong, Decai Zhang, Tiantian Yang, Ming Yi, Jingyi Tan, Shijia Ding, Wei Cheng
Analytical Methods.2022;[Epub]     CrossRef
VE1 immunohistochemistry is an adjunct tool for detection of BRAF V600E mutation: Validation in thyroid cancer patients
Faiza A. Rashid, Sobia Tabassum, Mosin S. Khan, Hifzur R. Ansari, Muhammad Asif, Ahmareen K. Sheikh, Syed Aga
Journal of Clinical Laboratory Analysis.2021;[Epub]     CrossRef
BRAF testing in a South African cohort of MLH1 deficient endometrial carcinomas: lessons learnt
Reubina Wadee, Wayne Grayson
Southern African Journal of Gynaecological Oncology.2021; 13(1): 1.     CrossRef
Association between mutation profiles and clinicopathological features in Chinese patients with thyroid cancer
Changwen Jing, Haixia Cao, Rong Ma, Jianzhong Wu, Zhuo Wang
Precision Medical Sciences.2021; 10(3): 113.     CrossRef
Development of a Molecular Assay for Detection and Quantification of the BRAF Variation in Residual Tissue From Thyroid Nodule Fine-Needle Aspiration Biopsy Specimens
Guodong Fu, Ronald S. Chazen, Christina MacMillan, Ian J. Witterick
JAMA Network Open.2021; 4(10): e2127243.     CrossRef
Variations in MAP kinase gladiators and risk of differentiated thyroid carcinoma
Faiza Rashid, Ghulam Bhat, Mosin Khan, Sobia Tabassum, Mohammad Bhat
Molecular and Clinical Oncology.2021;[Epub]     CrossRef
Evaluation of the expression levels of BRAFV600E mRNA in primary tumors of thyroid cancer using an ultrasensitive mutation assay
Tien Viet Tran, Kien Xuan Dang, Quynh Huong Pham, Ung Dinh Nguyen, Nhung Thi Trang Trinh, Luong Van Hoang, Son Anh Ho, Ba Van Nguyen, Duc Trong Nguyen, Dung Tuan Trinh, Dung Ngoc Tran, Arto Orpana, Ulf-Håkan Stenman, Jakob Stenman, Tho Huu Ho
BMC Cancer.2020;[Epub]     CrossRef
VE1 Immunohistochemistry Improves the Limit of Genotyping for Detecting BRAFV600E Mutation in Papillary Thyroid Cancer
Sonam Choden, Somboon Keelawat, Chan Kwon Jung, Andrey Bychkov
Cancers.2020; 12(3): 596.     CrossRef
Comparison of Molecular Methods and BRAF Immunohistochemistry (VE1 Clone) for the Detection of BRAF V600E Mutation in Papillary Thyroid Carcinoma: A Meta-Analysis
Kyle G. Parker, Michael G. White, Nicole A. Cipriani
Head and Neck Pathology.2020; 14(4): 1067.     CrossRef
Next generation sequencing based detection of 15 target genes mutations in papillary thyroid carcinoma
Zhuo Wang, Changwen Jing, Haixia Cao, SiWen Liu, Jianzhong Wu, Rong Ma
Precision Medical Sciences.2020; 9(2): 90.     CrossRef
A Systematic Review and Meta-Analysis of the Diagnostic Performance of BRAF V600E Immunohistochemistry in Thyroid Histopathology
Ranjit Singarayer, Ozgur Mete, Laure Perrier, Lehana Thabane, Sylvia L. Asa, Stan Van Uum, Shereen Ezzat, David P. Goldstein, Anna M. Sawka
Endocrine Pathology.2019; 30(3): 201.     CrossRef
Comparison of droplet digital PCR and direct Sanger sequencing for the detection of the BRAF V600E mutation in papillary thyroid carcinoma
Zhuo Wang, Kejing Sun, Changwen Jing, Haixia Cao, Rong Ma, Jianzhong Wu
Journal of Clinical Laboratory Analysis.2019;[Epub]     CrossRef
Immunohistochemistry Innovations for Diagnosis and Tissue-Based Biomarker Detection
Narittee Sukswai, Joseph D. Khoury
Current Hematologic Malignancy Reports.2019; 14(5): 368.     CrossRef
Immunohistochemistry is a feasible method to screen BRAF V600E mutation in colorectal and papillary thyroid carcinoma
Xiangyan Zhang, Lili Wang, Jigang Wang, Han Zhao, Jie Wu, Shuhong Liu, Lu Zhang, Yujun Li, Xiaoming Xing
Experimental and Molecular Pathology.2018; 105(1): 153.     CrossRef